|
Report Date : |
15.02.2012 |
IDENTIFICATION DETAILS
|
Name : |
SUNNY
PHARMACEUTICALS CO SAE |
|
|
|
|
Registered Office : |
Piece 37 & 38,
100 Fadan, Industrial Zone, Badr City, Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Date of Incorporation : |
2008 |
|
|
|
|
Com. Reg. No.: |
26581, Cairo |
|
|
|
|
Legal Form : |
Egyptian Joint
Stock Company |
|
|
|
|
Line of Business : |
Manufacturers of
pharmaceuticals and medical products |
|
|
|
|
No. of Employees : |
100 Employees. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 100,000 |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Egypt |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : SUNNY PHARMACEUTICALS CO SAE
Country of Origin : Egypt
Legal Form :
Egyptian Joint Stock Company
Registration Date : 2008
Commercial
Registration Number : 26581, Cairo
Tax Card Number : 261-905-554
Issued Capital : £E 26,000,000
Paid up Capital : £E
26,000,000
Total Workforce : 100
Activities :
Manufacturers of pharmaceuticals and medical products.
Financial Condition : Undetermined
Payments :
Nothing detrimental uncovered
Recommended Credit
Limit : US$ 100,000
Person Interviewed : Naghi Najuib,
Finance Manager
SUNNY
PHARMACEUTICALS CO SAE
Location : Piece 37 & 38, 100 Fadan
Area : Industrial Zone, Badr City
Town : Cairo
Country : Egypt
Telephone : (20-2) 23108143 / 23108144 / 23108145
Facsimile : (20-2) 23108140 / 23108148
Mobile : (20-122) 4201028
Email : nnajuib@sunnyph.com
Subject operates from
a medium sized suite of offices and a factory that are rented and located in
the Industrial Area of Cairo.
Branch Office
(s)
Location Description
·
33
Beirut Street Office
premises
Misr El Gedida
Cairo
Tel: (20-2) 24188605
Name Position
·
Dr
Nazmy Namees Masoud Chairman
·
Dr
Kareem Nazmy Namees Masoud Managing
Director
·
Dr
Ramez Nazmy Namees Masoud Director
·
Dr
Tharwat Hakim Operations
Manager
·
Naghi
Najuib Finance
Manager
·
Meri Rasmi
Nicole Purchasing
Manager
Date of Establishment : 2008,
production began in January 2012
Legal Form :
Egyptian Joint Stock
Company
Commercial Reg. No. : 26581, Cairo
Tax Card No. : 261-905-554
Issued Capital : £E 26,000,000
Paid up Capital : £E 26,000,000
·
Sunny
Medical Group
33 Beirut Street
Misr El Gedida
Cairo
Tel: (20-2) 24188605
·
Dr
Nazmy Namees Masoud
·
Dr
Kareem Nazmy Namees Masoud
·
Dr
Ramez Nazmy Namees Masoud
·
Local businessmen
and private investors
Activities: Engaged in the manufacture of
pharmaceuticals and medical products.
Import
Countries: Europe and the
Far East.
Subject has a
workforce of 100 employees.
Companies registered
in Egypt are not legally required to make their accounts public and no
financial information was released by the company or submitted by outside
sources.
·
Banque
Misr
151 Mohamed Farid Street
Cairo
Tel: (20-2) 33912711 / 33912106
Fax: (20-2) 33919779
No complaints
regarding subject’s payments have been reported.
Local sources
report that payment obligations are met in a generally timely manner and the
operating history is clear. As such the company is deemed a fair trade risk and
the above credit figure is considered to be within subject’s financial means.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.33 |
|
|
1 |
Rs.77.41 |
|
Euro |
1 |
Rs.64.83 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.